The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Fungal cell membrane-promising drug target for antifungal therapy
Abstract
Increase in invasive fungal infections over the past few years especially in immunocompromised patients prompted the search for new antifungal agents with improved efficacy. Current antifungal armoury includes very few effective drugs like Amphotericin B; new generation azoles, including voriconazole and posaconazole; echinocandins like caspofungin and micafungin to name a few. Azole class of antifungals which target the fungal cell membrane are the first choice of treatment for many years because of their effectiveness. As the fungal cell membrane is predominantly made up of sterols, glycerophospholipids and sphingolipids, the role of lipids in pathogenesis and target identification for improved therapeutics were largely pursued by researchers during the last few years. Present review focuses on cell membrane as an antifungal target with emphasis on membrane biogenesis, structure and function of cell membrane, cell membrane inhibitors, screening assays, recent advances and future prospects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An insight into the antifungal pipeline: selected new molecules and beyond
Ostrosky-Zeichner, L., Casadevall, A., Galgiani, J. N., Odds, F. C., & Rex, J. H. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3074 · Cited by 432
Aureobasidins, new antifungal antibiotics. Taxonomy, fermentation, isolation, and properties.
TAKESAKO, K., IKAI, K., HARUNA, F., ENDO, M., SHIMANAKA, K., SONO, E., NAKAMURA, T., KATO, I., & YAMAGUCHI, H. (1991) · The Journal of Antibiotics · doi:10.7164/antibiotics.44.919 · Cited by 149
Confronting the challenges of natural product-based antifungal discovery
Roemer, T., Xu, D., Singh, S. B., Parish, C. A., Harris, G., Wang, H., Davies, J. E., & Bills, G. F. (2011) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.01.009 · Cited by 147
Holmes, A. R., Keniya, M. V., Ivnitski-Steele, I., Monk, B. C., Lamping, E., Sklar, L. A., & Cannon, R. D. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05706-11 · Cited by 106
Cabral, M. E., Figueroa, L. I. C., & Fariña, J. I. (2013) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2012.09.006 · Cited by 54
Silicon Incorporated Morpholine Antifungals: Design, Synthesis, and Biological Evaluation
Jachak, G. R., Ramesh, R., Sant, D. G., Jorwekar, S. U., Jadhav, M. R., Tupe, S. G., Deshpande, M. V., & Reddy, D. S. (2015) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5b00245 · Cited by 52
Self-citationBiological consequences of statins in Candida species and possible implications for human health
Wikhe, K., Westermeyer, C., & Macreadie, I. G. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351529 · Cited by 31
Cited by
Campoy, S., & Adrio, J. L. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.11.019 · Cited by 511
Metadata
- Authors
- Sant, D. G., Tupe, S. G., Ramana, C. V., & Deshpande, M. V.
- Venue
- Journal of Applied Microbiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-11-02
- Volume
- 121
- Issue
- 6
- Pages
- 1498-1510
- ISSN
- 1364-5072 (ISSN-L)
- OpenAlex
- W2408957826
- Cited by
- 245
- References
- 7
- FWCI
- 6.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fungal cell membrane-promising drug target for antifungal therapy. https://app.cochat.ai/papers/10.1111/jam.13301
- The paper
- Sant, D. G., Tupe, S. G., Ramana, C. V., & Deshpande, M. V. (2016). Fungal cell membrane-promising drug target for antifungal therapy. Journal of Applied Microbiology. https://doi.org/10.1111/jam.13301
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.